SCHEMBL12425779

SCHEMBL12425779

CC(=O)N1CCCC2CN(C(=O)c3ccc(N)nc3)CC21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT5A Q9NQR1 1/20 0.43
ADRA1A P35348 3/20 0.40
L3MBTL3 Q96JM7 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PIK3CA P42336 4/20 0.37
MTOR P42345 4/20 0.37
GRM5 P41594 1/20 0.37
PDE2A O00408 1/20 0.37
HPGD P15428 1/20 0.37
TRPC6 Q9Y210 1/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426765 0.87 KMT5A (0.39) KMT5AADRA1AL3MBTL3L3MBTL1LMNA
SCHEMBL12425614 0.86 PIK3CA (0.50) KMT5APIK3CAMTORTRPC6
SCHEMBL12425803 0.86 DPP4 (0.43) KMT5AADRA1AL3MBTL3L3MBTL1LMNA
SCHEMBL12426766 0.82 PIK3CA (0.46) LMNAPIK3CAMTOR
SCHEMBL12425408 0.80 PIK3CA (0.41) KMT5AALDH1A1PIK3CAMTORTRPC6
SCHEMBL12425620 0.80 CYP3A4 (0.41) PIK3CAMTOR
SCHEMBL29230264 0.74 SMN1; SMN2 (0.50) ALDH1A1PIK3CAMTORGRM5HPGD
SCHEMBL31697636 0.74 SMN1; SMN2 (0.50) ALDH1A1PIK3CAMTORGRM5HPGD
SCHEMBL12425404 0.74 L3MBTL3 (0.51) L3MBTL3L3MBTL1PIK3CAMTORHPGD
SCHEMBL12425600 0.73 CHRNA4 (0.60) L3MBTL3L3MBTL1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101409-A1 PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 NOVARTIS AG (CH) 2011-08-25 WO disclosed